查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439640

神经血管栓塞装置 - 全球市场考量、竞争格局、市场预测 (2030)

Neurovascular Embolization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球神经血管栓塞器械市场规模将于 2023 年达到 12.9 亿美元，到 2030 年将达到 15.9 亿美元，预计在 2024-2030 年预测期内复合年增长率为 3.50%。 神经血管栓塞装置的需求增加主要是由于脑出血和血管异常的盛行率不断增加，以及久坐生活方式导致的脑动脉瘤和动静脉畸形（AVM）的增加。 此外，老年人口的增加、高血压盛行率的增加、各种栓塞产品的推出等是全球神经血管栓塞器械市场的成长因素。

神经血管栓塞装置的市场动态

由于人类出血和脑动脉瘤盛行率不断上升，神经血管栓塞设备市场目前正在蓬勃发展。 根据公共卫生系统国民医疗服务体系(NHS) 的说法，有许多因素会增加脑动脉瘤的风险，包括吸烟、严重头部外伤、滥用古柯碱和血压升高。这可能会导致脑动脉瘤风险增加。需求。 例如，根据世界卫生组织（WHO）2023年发布的数据，全球约12.8亿30岁至79岁的成年人患有高血压。 数据也显示，三分之二的高血压患者生活在低收入和中等收入国家。

此外，老年人口的持续扩张也可能在未来几年对神经血管栓塞器械市场做出贡献。 脑动脉瘤在30岁至60岁之间的成年人更常见，且女性比男性更常见。 联合国经济和社会事务部人口司（UN DESA）发布的《2020年世界人口老化要点》预计，2020年全球65岁以上人口将达7.27亿人。 根据同一份报告，女性占老年人尤其是老年人的大多数，到2020年，女性占全球65岁及以上人口的55%。

此外，栓塞产品的核准也可能有助于市场成长。 例如，Terumo公司开发的囊内血流阻断装置Woven EndoBridge（WEB）动脉瘤栓塞系统于2019年获得美国FDA核准。

因此，所有上述因素预计将在预测期内加强对神经血管栓塞设备的需求。

然而，与神经血管栓塞相关的某些併发症，例如微导管、微导丝、线圈等引起的动脉瘤穿孔，可能会抑制市场。

史无前例的 COVID-19 大流行正在减缓神经血管栓塞设备市场的发展。 这是由于一些国家正在实施封锁、社会疏离规范和反传播措施。 此外，除了停止手术、减少蛛网膜下腔出血 (SAH) 住院人数以及对破裂动脉瘤进行弹簧圈栓塞干预以防止病毒传播外，大多数重症监护病房 (ICU) 现已对 COVID-19 患者关闭。由于大量涌入导致的饱和，医护人员对控制疫情的关注也影响了市场。

神经血管栓塞器械市场细分分析

在神经血管栓塞装置产品类型领域，预计栓塞弹簧圈在预测期内将占重要的市场占有率。 这是由于栓塞线圈的广泛使用以及製造商加大力度开发先进的栓塞线圈，这可能会提高患者群体中的设备采用率。 例如，2019 年 10 月 21 日，Shape Memory Medical 的 TrelliX 栓塞线圈系统获得了 CE 标誌，该系统采用专有的形状记忆聚合物 (SMP) 技术。

此外，2019年9月17日，沃比医疗推出了一种差异化药物，用于颅内动脉瘤和其他神经血管异常（如动静脉畸形和动静脉瘘管）的血管内栓塞治疗。我们获得了CE标誌批准和FDA 510(k)许可。我们的栓塞线圈系统，Avenir 线圈系统。 该系统提供全系列的捲材，包括高度稳定的框架卷材、高容量的填充卷材和极其灵活的精加工卷材。

本报告研究和分析了全球神经血管栓塞器械市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第1章神经血管栓塞器械市场报告简介

第 2 章神经血管栓塞器械市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估
  • 财务基准

第3章监理与专利分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章神经血管栓塞器材市场关键因素分析

  • 神经血管栓塞器械市场的驱动因素
    • 由于严重头部外伤、久坐的生活方式等，神经血管疾病（如脑动脉瘤和出血）的盛行率增加。
    • 全球高血压盛行率不断上升
    • 世界各地的产品核准和上市量增加
    • 人口老化负担日益加重
  • 神经血管栓塞器材市场的限制与挑战
    • 与栓塞弹簧圈相关的併发症
    • 严格的监管审批
  • 神经血管栓塞器材市场机会
    • 中低收入地区的成长机会
    • 透过大公司之间的策略伙伴关係获得成长机会

第5章神经血管栓塞装置波特五力分析

第6章COVID-19对神经血管栓塞器材市场的影响分析

第7章神经血管栓塞器械市场布局

  • 依产品类型
    • 栓塞线圈
    • 神经血管线圈辅助装置
    • 液体栓塞系统
    • 血流调节支架
    • 囊内血流阻断装置
    • 其他
  • 按最终用户
    • 医院
    • 门诊手术中心
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第 8 章神经血管栓塞装置：全球公司占有率分析 - 3 至 5 家主要公司

第9章神经血管栓塞器械公司及产品简介

  • Medtronic
  • Stryker
  • MicroVention, Inc. (Terumo Corporation)
  • Johnson & Johnson Services, Inc.
  • Penumbra, Inc.
  • Balt
  • B. Braun Melsungen AG
  • Acandis GmbH
  • Wallaby Medical
  • Shape Memory Medical Inc.
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • Spartan Micro, Inc.
  • KANEKA CORPORATION
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Boston Scientific Corporation
  • phenox GmbH
  • Merit Medical Systems
  • Perflow Medical Ltd
  • MicroPort Scientific Corporation.
  • Cerus Endovascular
  • Rapid Medical

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络资讯

Product Code: DIMDCL0477

Neurovascular Embolization Devices Market By Product Type (Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents And Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others), By End-User (Hospitals, Ambulatory Surgical Centers), by geography, is expected to expand at a static CAGR forecast till 2030 due to the rising cases of hemorrhages and brain aneurysm in the population across the globe and launch of embolization products in different regions worldwide

The global neurovascular embolization devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 3.50% during the forecast period from 2024 to 2030, to reach USD 1.59 billion by 2030. The rise in the demand for neurovascular embolization devices is predominantly attributed to the increasing prevalence of hemorrhages and the abnormalities in blood vessels present in the brain, increasing brain aneurysms and arteriovenous malformations (AVMs) due to sedentary lifestyles. Moreover, the rise in the geriatric population, increasing prevalence of high blood pressure, the launch of various embolization products, among others are the factors responsible for the global neurovascular embolization devices market growth.

Neurovascular Embolization Devices Market Dynamics:

The market for neurovascular embolization devices is gaining momentum at present owing to the rise in prevalence of hemorrhages and brain aneurysms among the population. According to the National Health Service (NHS), a publicly funded healthcare system, there are a lot of factors such as smoking, severe head injury, cocaine abuse, increase in blood pressure, among others that increases the risk of developing brain aneurysm among the population, thus would lead to an increase in the demand for neurovascular embolization devices. For instance, according to the data published by the World Health Organization (WHO) in the year 2023, approximately 1.28 billion adults aged between 30-79 years have hypertension across the globe. Also, the data mentioned that two-third of the population suffering from hypertension are living in low- and middle-income countries.

Furthermore, the ongoing expansion of the geriatric population would also contribute to the neurovascular embolization devices market in the forthcoming years. This is because brain aneurysm is common in adults between the ages of 30 and 60 and are more common in women than in men. According to the World Population Ageing 2020 Highlights published by the Population Division of the United Nations Department of Economic and Social Affairs (UN DESA), there were an estimated 727 million persons aged 65 years and above across the globe in the year 2020. As per the same report, women comprised of a majority of the older person, especially at an advanced age, and accounted for 55% of the global population aged 65 years and over in the year 2020.

In addition, approval of embolization products would also contribute to market growth. For instance, Woven EndoBridge (WEB) Aneurysm Embolization System, an Intrasaccular Flow Disruption Device developed by Terumo Corporation was approved by the US FDA in the year 2019.

Hence, all the aforementioned factors are anticipated to bolster the demand for neurovascular embolization devices during the forecasted period.

However, certain complications associated with the neurovascular embolization procedures such as procedural aneurysmal perforations by the microcatheter, micro-guidewire, or coil, among others are likely to impede the market.

The unprecedented COVID-19 pandemic has slowed down the market for neurovascular embolization devices. This is owing to the implementation of lockdown, the social distancing norms, and containment measures in several countries. Moreover, halt in surgeries, decreased volumes in subarachnoid hemorrhage (SAH) hospitalizations, and ruptured aneurysm coiling interventions to prevent the transmission of the virus, shifting focus of healthcare professionals to manage the pandemic as most of the intensive care units (ICU) were saturated with the massive influx of COVID-19 patients, among others also affected the market.

Neurovascular Embolization Devices Market Segment Analysis:

Neurovascular Embolization Devices Market By Product Type (Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents and Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others), By End-User (Hospitals, Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Neurovascular Embolization Devices product type segment, the embolization coil is anticipated to hold a significant market share during the forecasted period. This is due to the wide availability of embolization coils and growing initiatives by the manufacturers to develop advanced embolization coils which in turn would increase the adoption rate of the devices among the patient population. For instance, on October 21, 2019, Shape Memory Medical received CE Mark for the TrelliX® Embolic Coil System which features proprietary shape memory polymer (SMP) technology.

Also, on September 17, 2019, Wallaby Medical received CE Mark approval and FDA 510(k) clearance for its differentiated embolic coil system, the Avenir Coil System intended to use for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The system offers a full line of coils including exceptional stable framing coils, extra volume filling coils, and ultra-soft finishing coils.

In addition, companies raising funds for the development and commercialization of neurovascular embolic coils are also expected to contribute to the segmental growth of the neurovascular embolization devices market. For instance, in July 2022, Zylox-Tonbridge Medical Technology Co., Ltd., a neuro- and peripheral-vascular interventional medical device company raised USD 329 million to support the development and commercialization of its core products which include neurovascular embolization coils, a micro catheter for coiling, among others.

Thus, all the above-mentioned factors would boost the market for neurovascular embolization devices in the upcoming years.

North America is expected to dominate the overall Neurovascular Embolization Devices Market:

Among all the regions, North America is expected to occupy a major share in the overall neurovascular embolization devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of key market players and the recent launch of embolization products in the region is anticipated to propel the neurovascular embolization market.

For instance, as per the 2022 data of the Brain Aneurysm Foundation, an estimated 6.5 million people in the US have an unruptured brain aneurysm in the year 2020 and about 30,000 people suffer from a brain aneurysm rupture each year.

In addition, an increase in government initiatives and funding to support research for brain aneurysms in the country would also increase the regional market for neurovascular embolization devices. For instance, as per the bill presented in the 117 session on March 03, 2022, USD 10,000,000 has been funded by the government to conduct or support further comprehensive research on unruptured intracranial aneurysms for each of fiscal years 2022 through 2028 which will remain available through September 30, 2029.

Moreover, strategic business activities and approval of products in the region would also boost the regional market for neurovascular embolization devices. For instance, in the year 2020, Kaneka Corporation received FDA approval for its new brain aneurysm Embolization coil, i-ED COIL(TM).

Hence, the interplay of all the aforementioned factors will bolster the demand for the neurovascular embolization market in the region during the forecasted period.

Furthermore, the Asia-pacific region has future potential for the neurovascular embolization devices market. This is owing to the rising sedentary lifestyle such as consumption of alcohol, increase in aging population, growing head injuries, among others. For instance, as per the World Bank Group 2022 data, in the year 2020, China had 168,863,853 population aged 65 and above.

In addition, strategic business activity to expand the domestic market in the APAC region would also contribute to the neurovascular embolization devices market. For instance, in the year 2020, Genesis MedTech Group acquired Minitech Medical, a leading domestic enterprise in the neurovascular industry, and successfully developed and launched its first domestically-made intracranial embolization stent. Hence, all of these factors are likely to make APAC the fastest market for neurovascular embolization devices during the forecasted period.

Neurovascular Embolization Devices Market Key Players:

Some of the key market players operating in the Neurovascular Embolization Devices market include Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.

Recent Developmental Activities in the Neurovascular Embolization Devices Market:

In October 2020, Shanghai MicroPort NeuroTech Co., Ltd. ("MicroPort® NeuroTech") received the registration certificates issued by China's National Medical Products Administration (NMPA) for its proprietary NUMEN Coil Embolization System and NUMEN FR Coil Detachment System for the treatment of cerebral aneurysms through minimally invasive neurovascular intervention.

In April 2020, Cerus Endovascular received CE Mark approval for its Neqstent Coil Assisted Flow Diverter device designed for the treatment of intracranial aneurysms.

In May 2019, Rapid Medical, a company focused on the development of next-generation neurovascular devices, received FDA clearance for the Comaneci device as a temporary coil embolization assist device.

Key Takeaways from the Neurovascular Embolization Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurovascular Embolization Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Neurovascular Embolization Devices Market.

Various opportunities available for the other competitor in the Neurovascular Embolization Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Neurovascular Embolization Devices market growth in the coming future?

Target Audience who can be benefited from the Neurovascular Embolization Devices Market Report Study

Neurovascular Embolization Devices providers

Research organizations and consulting companies

Neurovascular Embolization Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Neurovascular Embolization Devices

Various End-users who want to know more about the Neurovascular Embolization Devices Market and latest technological developments in the Neurovascular Embolization Devices market.

Frequently Asked Questions for the Neurovascular Embolization Devices Market:

1. What are Neurovascular Embolization Devices?

A neurovascular embolization device is an intravascular implant intended to permanently occlude blood flow to cerebral aneurysms and cerebral arteriovenous malformations.

2. What is the market for Global Neurovascular Embolization Devices?

The global neurovascular embolization devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 3.50% during the forecast period from 2024 to 2030, to reach USD 1.59 billion by 2030.

3. What are the drivers for the Global Neurovascular Embolization Devices?

The major factors driving the demand for Neurovascular Embolization Devices are the rising cases of hemorrhage stroke, brain aneurysm, and cerebral arteriovenous malformations due to sedentary lifestyles such as excessive consumption of alcohol, serious head injuries, and others. In addition, the rising prevalence of high blood pressure, growing product approval, and increase in the aging population, among others are also expected to boost the market.

4. What are the key players operating in Global Neurovascular Embolization Devices?

Some of the key market players operating in the Neurovascular Embolization Devices market include Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.

5. Which region has the highest share in the Neurovascular Embolization Devices market?

Among all the regions, North America is expected to occupy a major share in the overall neurovascular embolization devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of key market players and the recent launch of embolization products in the region is anticipated to propel the neurovascular embolization market.

Table of Contents

1.Neurovascular Embolization Devices Market Report Introduction

2.Neurovascular Embolization Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Neurovascular Embolization Devices Market Key factors analysis

  • 4.1 Neurovascular Embolization Devices Market Drivers
    • 4.1.1 Growing prevalence of neurovascular disorders such as brain aneurysm, hemorrhage, and others due to severe head injuries, sedentary lifestyle, others
    • 4.1.2 Increase in prevalence of hypertension across the globe
    • 4.1.3 Increasing product approval & launches across the globe
    • 4.1.4 The growing burden of the geriatric population
  • 4.2 Neurovascular Embolization Devices Market Restraints and Challenges
    • 4.2.1 Complications associated with embolization coils
    • 4.2.2 Stringent regulatory approvals
  • 4.3 Neurovascular Embolization Devices Market Opportunities
    • 4.3.1 Growth opportunities in low and middle-income regions
    • 4.3.2 Growth opportunities due to strategic partnership among key players

5. Neurovascular Embolization Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Neurovascular Embolization Devices Market

7. Neurovascular Embolization Devices Market layout

  • 7.1 By Product Type
    • 7.1.1 Embolization Coils
    • 7.1.2 Neurovascular Coil Assist Devices
      • 7.1.2.1 Coil Assist Stents
      • 7.1.2.2 Coil Assist Balloons
    • 7.1.3 Liquid Embolization Systems
    • 7.1.4 Flow diversion stents
    • 7.1.5 Intrasaccular flow disruptor
    • 7.1.6 Others
  • 7.2 By End-user
    • 7.2.1 Hospitals
    • 7.2.2 Ambulatory Surgical Centers
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 North America Neurovascular Embolization Devices Market, by Product Type
      • 7.3.1.2 North America Neurovascular Embolization Devices Market, by End User
      • 7.3.1.3 North America Neurovascular Embolization Devices Market, by Country
      • 7.3.1.3.1 United States
      • 7.3.1.3.2 Canada
      • 7.3.1.3.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 Europe Neurovascular Embolization Devices Market, by Product Type
      • 7.3.2.2 Europe Neurovascular Embolization Devices Market, by End User
      • 7.3.2.3 Europe Neurovascular Embolization Devices Market, by Country
      • 7.3.2.3.1 France
      • 7.3.2.3.2 Germany
      • 7.3.2.3.3 United Kingdom
      • 7.3.2.3.4 Italy
      • 7.3.2.3.5 Spain
      • 7.3.2.3.6 Russia
      • 7.3.2.3.7 Rest of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 Asia-Pacific Neurovascular Embolization Devices Market, by Product Type
      • 7.3.3.2 Asia-Pacific Neurovascular Embolization Devices Market, by End User
      • 7.3.3.3 Asia-Pacific Neurovascular Embolization Devices Market, by Country
      • 7.3.3.3.1 China
      • 7.3.3.3.2 Japan
      • 7.3.3.3.3 India
      • 7.3.3.3.4 Australia
      • 7.3.3.3.5 South Korea
      • 7.3.3.3.6 Rest of Asia Pacific
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1 RoW Neurovascular Embolization Devices Market, by Product Type
      • 7.3.4.2 RoW Neurovascular Embolization Devices Market, by End User
      • 7.3.4.3 RoW Neurovascular Embolization Devices Market, by Region
      • 7.3.4.3.1 Middle East
      • 7.3.4.3.2 Africa
      • 7.3.4.3.3 South America

8. Neurovascular Embolization Devices Global Company Share Analysis - Key 3-5 Companies

9. Neurovascular Embolization Devices Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Stryker
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 MicroVention, Inc. (Terumo Corporation)
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Johnson & Johnson Services, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Penumbra, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Balt
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 B. Braun Melsungen AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Acandis GmbH
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Wallaby Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Shape Memory Medical Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Zylox-Tonbridge Medical Technology Co., Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Spartan Micro, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 KANEKA CORPORATION
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Lepu Medical Technology (Beijing) Co., Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Meril Life Sciences Pvt. Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Boston Scientific Corporation
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 phenox GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Merit Medical Systems
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Perflow Medical Ltd
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 MicroPort Scientific Corporation.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy
  • 9.21 Cerus Endovascular
    • 9.21.1. Company Overview
    • 9.21.2. Company Snapshot
    • 9.21.3. Financial Overview
    • 9.21.4 Product Listing
    • 9.21.5. Entropy
  • 9.22 Rapid Medical
    • 9.22.1. Company Overview
    • 9.22.2. Company Snapshot
    • 9.22.3. Financial Overview
    • 9.22.4 Product Listing
    • 9.22.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Neurovascular Embolization Devices Market
  • Table 3 Neurovascular Embolization Devices Market Analysis in Global (2021-2030)
  • Table 4 Neurovascular Embolization Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Neurovascular Embolization Devices Market Analysis in Global by End User (2021-2030)
  • Table 6 Neurovascular Embolization Devices Market Analysis in Global by Geography (2021-2030)
  • Table 7 Neurovascular Embolization Devices Market Analysis in North America (2021-2030)
  • Table 8 Neurovascular Embolization Devices Market Analysis in North America by Product Type (2021-2030)
  • Table 9 Neurovascular Embolization Devices Market Analysis in North America by End User (2021-2030)
  • Table 10 Neurovascular Embolization Devices Market Analysis in North America by Country (2021-2030)
  • Table 11 Neurovascular Embolization Devices Market Analysis in the US (2021-2030)
  • Table 12 Neurovascular Embolization Devices Market Analysis in Canada (2021-2030)
  • Table 13 Neurovascular Embolization Devices Market Analysis in Mexico (2021-2030)
  • Table 14 Neurovascular Embolization Devices Market Analysis in Europe (2021-2030)
  • Table 15 Neurovascular Embolization Devices Market Analysis in Europe by Product Type (2021-2030)
  • Table 16 Neurovascular Embolization Devices Market Analysis in Europe by End User (2021-2030)
  • Table 17 Neurovascular Embolization Devices Market Analysis in Europe by Country (2021-2030)
  • Table 18 Neurovascular Embolization Devices Market Analysis in France (2021-2030)
  • Table 19 Neurovascular Embolization Devices Market Analysis in Germany (2021-2030)
  • Table 20 Neurovascular Embolization Devices Market Analysis in the UK (2021-2030)
  • Table 21 Neurovascular Embolization Devices Market Analysis in Italy (2021-2030)
  • Table 22 Neurovascular Embolization Devices Market Analysis in Spain (2021-2030)
  • Table 23 Neurovascular Embolization Devices Market Analysis in Russia (2021-2030)
  • Table 24 Neurovascular Embolization Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 25 Neurovascular Embolization Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 26 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 27 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 28 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 29 Neurovascular Embolization Devices Market Analysis in China (2021-2030)
  • Table 30 Neurovascular Embolization Devices Market Analysis in Japan (2021-2030)
  • Table 31 Neurovascular Embolization Devices Market Analysis in India (2021-2030)
  • Table 32 Neurovascular Embolization Devices Market Analysis in Australia (2021-2030)
  • Table 33 Neurovascular Embolization Devices Market Analysis in South Korea (2021-2030)
  • Table 34 Neurovascular Embolization Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 35 Neurovascular Embolization Devices Market Analysis in Rest of World (2021-2030)
  • Table 36 Neurovascular Embolization Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 37 Neurovascular Embolization Devices Market Analysis in Rest of World by End User (2021-2030)
  • Table 38 Neurovascular Embolization Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 39 Neurovascular Embolization Devices Market Analysis in the Middle East (2021-2030)
  • Table 40 Neurovascular Embolization Devices Market Analysis in Africa (2021-2030)
  • Table 41 Neurovascular Embolization Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Neurovascular Embolization Devices Market
  • Figure 3 Neurovascular Embolization Devices Market Analysis in Global (2021-2030)
  • Figure 4 Neurovascular Embolization Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Neurovascular Embolization Devices Market Analysis in Global by End User (2021-2030)
  • Figure 6 Neurovascular Embolization Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 7 Neurovascular Embolization Devices Market Analysis in North America (2021-2030)
  • Figure 8 Neurovascular Embolization Devices Market Analysis in North America by Product Type (2021-2030)
  • Figure 9 Neurovascular Embolization Devices Market Analysis in North America by End User (2021-2030)
  • Figure 10 Neurovascular Embolization Devices Market Analysis in North America by Country (2021-2030)
  • Figure 11 Neurovascular Embolization Devices Market Analysis in the US (2021-2030)
  • Figure 12 Neurovascular Embolization Devices Market Analysis in Canada (2021-2030)
  • Figure 13 Neurovascular Embolization Devices Market Analysis in Mexico (2021-2030)
  • Figure 14 Neurovascular Embolization Devices Market Analysis in Europe (2021-2030)
  • Figure 15 Neurovascular Embolization Devices Market Analysis in Europe by Product Type (2021-2030)
  • Figure 16 Neurovascular Embolization Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 17 Neurovascular Embolization Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 18 Neurovascular Embolization Devices Market Analysis in France (2021-2030)
  • Figure 19 Neurovascular Embolization Devices Market Analysis in Germany (2021-2030)
  • Figure 20 Neurovascular Embolization Devices Market Analysis in the UK (2021-2030)
  • Figure 21 Neurovascular Embolization Devices Market Analysis in Italy (2021-2030)
  • Figure 22 Neurovascular Embolization Devices Market Analysis in Spain (2021-2030)
  • Figure 23 Neurovascular Embolization Devices Market Analysis in Russia (2021-2030)
  • Figure 24 Neurovascular Embolization Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 25 Neurovascular Embolization Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 26 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 27 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 28 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 29 Neurovascular Embolization Devices Market Analysis in China (2021-2030)
  • Figure 30 Neurovascular Embolization Devices Market Analysis in Japan (2021-2030)
  • Figure 31 Neurovascular Embolization Devices Market Analysis in India (2021-2030)
  • Figure 32 Neurovascular Embolization Devices Market Analysis in Australia (2021-2030)
  • Figure 33 Neurovascular Embolization Devices Market Analysis in South Korea (2021-2030)
  • Figure 34 Neurovascular Embolization Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 35 Neurovascular Embolization Devices Market Analysis in Rest of World (2021-2030)
  • Figure 36 Neurovascular Embolization Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 37 Neurovascular Embolization Devices Market Analysis in Rest of World by End User (2021-2030)
  • Figure 38 Neurovascular Embolization Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 39 Neurovascular Embolization Devices Market Analysis in the Middle East (2021-2030)
  • Figure 40 Neurovascular Embolization Devices Market Analysis in Africa (2021-2030)
  • Figure 41 Neurovascular Embolization Devices Market Analysis in South America (2021-2030)
  • Figure 42 Market Drivers
  • Figure 43 Market Barriers
  • Figure 44 Market Opportunities
  • Figure 45 PORTER's Five Force Analysis